SCA
PFE icon

Strategic Capital Alternatives’s Pfizer PFE Stock Holding History

Strategic Capital Alternatives’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$3.85M Sell
129,230
-100,169
-44% -$3.21M 0.82% 31
2015
Q2 		$7.38M Buy
229,399
+3,236
+1% +$105K 1.78% 10
2015
Q1 		$7.46M Buy
226,163
+76,594
+51% +$2.44M 1.86% 9
2014
Q4 		$4.42M Sell
149,569
-164
-0.1% -$4.7K 1.72% 13
2014
Q3 		$4.2M Buy
+149,733
New +$4.2M 1.48% 16

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Strategic Capital Alternatives's PFE Position: Q3 2015 in Review

Strategic Capital Alternatives reduced its Pfizer (PFE) stake by 44% in Q3 2015, selling an estimated $3.21M and leaving 129,230 shares worth $3.85M. The position accounts for 0.82% of the portfolio, ranked #31.

Strategic Capital Alternatives first reported a position in PFE in Q3 2014 and has held it in 5 quarters since. The position peaked at $7.46M in Q1 2015. 1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

  • Strategic Capital Alternatives held 129,230 shares of Pfizer worth $3.85M as of Q3 2015.
  • Strategic Capital Alternatives sold 100,169 Pfizer shares in Q3 2015, an estimated $3.21M.
  • Pfizer made up 0.82% of Strategic Capital Alternatives's portfolio in Q3 2015, its #31 holding.
  • Strategic Capital Alternatives first reported a position in Pfizer in Q3 2014 and has held it in 5 quarters since.
  • Strategic Capital Alternatives's Pfizer position peaked at $7.46M in Q1 2015.
  • 1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.